The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma
Open accessAbstract
Evidence suggests that multiple tumors, including pancreatic adenocarcinoma, display heterogeneity in parameters that are critical for tumor formation, progression and metastasis. Understanding heterogeneity in solid tumors is increasingly providing a plethora of new diagnostic and therapeutic approaches. In this study, a particular focus was put on identifying a subpopulation of stem cell-like, slow cycling tumor cells in a pancreas adenocarcinoma cell lines. Using a label retention technique a subpopulation of slow cycling cells (DiI+/SCC) was identified and further evaluated in the BxPC-3 and Panc03.27 cell lines. These slowly cycling cells managed to retain the lipophilic labeling dye DiI, while the bulk of the cells (>94%) did not. The DiI+/SCC population, showed only a partial overlap with the CSC markers CD24(+)/CD44(+), CD133(+) and ALDH but they survived chemotherapeutic treatment, and were able to recreate the initial heterogeneous tumor cell population. DiI+/SCCs exhibited an increased invasive potential as compared with their non-label retaining, faster cycling cells (DiI-/FCC). They also had increased tumorigenic potential and morphological changes resembling cells that have undergone an epithelial to mesenchymal transition (EMT). Analysis of DiI+/SCC cells by real time PCR revealed a selective up-regulation of tell tale components of the Hedgehog/TGFbeta pathways, as well as a down-regulation of EGFR, combined with a shift in crucial components implied in EMT. The presented findings offer an expanded mechanistic understanding that associates tumor initiating potential with cycling speed and EMT in pancreatic cancer cell lines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
Identification and expansion of human colon-cancer-initiating cells
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & De Maria, R. (2007) · Nature · doi:10.1038/nature05384 · Cited by 3,998
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668 · cited 1×
“However, resistance to chemotherapy may also be due to other mechanisms, including highly active drug pumps [15].”
BackgroundIdentification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., & Heeschen, C. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.06.002 · Cited by 2,897
Prospective Identification of Tumorigenic Prostate Cancer Stem Cells
Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J., & Maitland, N. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2018 · Cited by 2,820
An Overview of Epithelio-Mesenchymal Transformation
Hay, E. D. (1995) · Cells Tissues Organs · doi:10.1159/000147748 · Cited by 1,567
Clement, V., Sanchez, P., de Tribolet, N., Radovanovic, I., & Ruiz i Altaba, A. (2007) · Current Biology · doi:10.1016/j.cub.2006.11.033 · Cited by 1,050
Spaeth, E. L., Dembinski, J. L., Sasser, A. K., Watson, K., Klopp, A., Hall, B., Andreeff, M., & Marini, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004992 · Cited by 807
Self-citationPolymorphism in Sirpa modulates engraftment of human hematopoietic stem cells
Takenaka, K., Prasolava, T. K., Wang, J. C. Y., Mortin-Toth, S. M., Khalouei, S., Gan, O. I., Dick, J. E., & Danska, J. S. (2007) · Nature Immunology · doi:10.1038/ni1527 · Cited by 509
Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells
Shah, A. N., Summy, J. M., Zhang, J., Park, S. I., Parikh, N. U., & Gallick, G. E. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9583-5 · Cited by 433
Preferential induction of apoptosis for primary human leukemic stem cells
Guzman, M. L., Swiderski, C. F., Howard, D. S., Grimes, B. A., Rossi, R. M., Szilvassy, S. J., & Jordan, C. T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252462599 · Cited by 426
Deaths: Final Data for 2003: (518032006-001)
Hoyert, D. L., Heron, M. P., Murphy, S. L., & Kung, H.-C. (2006) · PsycEXTRA Dataset · doi:10.1037/e518032006-001 · Cited by 362
Dennler, S., André, J., Alexaki, I., Li, A., Magnaldo, T., ten Dijke, P., Wang, X.-J., Verrecchia, F., & Mauviel, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0491 · Cited by 342
Costello, R. T., Mallet, F., Gaugler, B., Sainty, D., Arnoulet, C., Gastaut, J., & Olive, D. (2000) · PubMed · Cited by 287
Jimeno, A., Feldmann, G., Suárez-Gauthier, A., Rasheed, Z., Solomon, A., Zou, G.-M., Rubio-Viqueira, B., García-García, E., López-Ríos, F., Matsui, W., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0924 · Cited by 276
Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis
Morton, J. P., Mongeau, M. E., Klimstra, D. S., Morris, J. P., Lee, Y. C., Kawaguchi, Y., Wright, C. V. E., Hebrok, M., & Lewis, B. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701158104 · Cited by 223
Bailey, J. M., Singh, P. K., & Hollingsworth, M. A. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21509 · Cited by 209
Batard, P., Monier, M., Fortunel, N. O., Ducos, K., Sansilvestri, P., Phan, T.-H., Hatzfeld, A., & Hatzfeld, J. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.3.383 · Cited by 166
Zemskova, M., Sahakian, E., Bashkirova, S., & Lilly, M. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709479200 · Cited by 129
Garcea, G., Weaver, J., Phillips, J., Pollard, C. A., Illouz, S. C., Webb, M. A., Berry, D. P., & Dennison, A. R. (2008) · Pancreas · doi:10.1097/mpa.0b013e3181825c00 · Cited by 119
Chemotherapy for pancreatic cancer
Shore, S., Raraty, M. G. T., Ghaneh, P., & Neoptolemos, J. P. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2003.01781.x · Cited by 82
EMT and MET in carcinoma—clinical observations, regulatory pathways and new models
Thompson, E. W., & Williams, E. D. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9189-8 · Cited by 76
Epithelial-Mesenchymal Transition Markers in Pancreatic Ductal Adenocarcinoma
Cates, J., Byrd, R. H., Fohn, L. E., Tatsas, A. D., Washington, M. K., & Black, C. C. (2008) · Pancreas · doi:10.1097/mpa.0b013e3181878b7f · Cited by 76
Krishnamurthy, K., Wang, G., Rokhfeld, D., & Bieberich, E. (2008) · Breast Cancer Research · doi:10.1186/bcr2211 · Cited by 67
Frankel, A., Rosen, K. V., Filmus, J., & Kerbel, R. S. (2001) · PubMed · Cited by 61
Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma
Huang, P., Wang, C., Gou, S., Wu, H., Liu, T., & Xiong, J.-X. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3903 · Cited by 55
Fairley, E. A. L., Riddell, A., Ellis, J. A., & Kendrick‐Jones, J. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.2.341 · Cited by 54
Li, N., Yang, H., Lu, L., Duan, C., Zhao, C., & Zhao, H. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.095 · Cited by 46
Hyaluronan substratum holds mesenchymal stem cells in slow-cycling mode by prolonging G1 phase
Liu, C.-M., Yu, C.-H., Chang, C., Hsu, C., & Huang, L. L. H. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0699-0 · Cited by 25
Cited by
The role of the Hedgehog signaling pathway in cancer: A comprehensive review
Skoda, A. M., Simovic, D., Karin, V., Kardum, V., Vranic, S., & Serman, L. (2018) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2018.2756 · Cited by 781
Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
Zhang, Y., & Weinberg, R. A. (2018) · Frontiers of Medicine · doi:10.1007/s11684-018-0656-6 · Cited by 663
Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets
Park, J. H., Pyun, W. Y., & Park, H. W. (2020) · Cells · doi:10.3390/cells9102308 · Cited by 548
Drug Resistance Driven by Cancer Stem Cells and Their Niche
Prieto-Vila, M., Takahashi, R.-U., Usuba, W., Kohama, I., & Ochiya, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122574 · Cited by 508
Cancer stem cells and chemoresistance: The smartest survives the raid
Zhao, J. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.02.008 · Cited by 437
Metadata
- Authors
- Dembinski, J. L., & Krauss, S.
- Venue
- Clinical & Experimental Metastasis
- Published
- 2009-05-07
- Volume
- 26
- Issue
- 7
- Pages
- 611-623
- ISSN
- 0262-0898 (ISSN-L)
- 1573-7276
- OpenAlex
- W2031348772
- Cited by
- 271
- References
- 35
- FWCI
- 8.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.